Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

5CE0

Crystal structure of conserpin with Z-mutation

5CE0 の概要
エントリーDOI10.2210/pdb5ce0/pdb
関連するPDBエントリー5CDX 5CDZ 5CE2
分子名称Native conserpin with Z-variant (E342K) (2 entities in total)
機能のキーワードserine protease inhibitor, aggregation resistant, consensus design, stability, z-variant, hydrolase inhibitor
由来する生物種synthetic construct
タンパク質・核酸の鎖数2
化学式量合計85156.80
構造登録者
Porebski, B.T.,McGowan, S.,Keleher, S.,Buckle, A.M. (登録日: 2015-07-06, 公開日: 2016-07-20, 最終更新日: 2023-09-27)
主引用文献Porebski, B.T.,Keleher, S.,Hollins, J.J.,Nickson, A.A.,Marijanovic, E.M.,Borg, N.A.,Costa, M.G.,Pearce, M.A.,Dai, W.,Zhu, L.,Irving, J.A.,Hoke, D.E.,Kass, I.,Whisstock, J.C.,Bottomley, S.P.,Webb, G.I.,McGowan, S.,Buckle, A.M.
Smoothing a rugged protein folding landscape by sequence-based redesign.
Sci Rep, 6:33958-33958, 2016
Cited by
PubMed Abstract: The rugged folding landscapes of functional proteins puts them at risk of misfolding and aggregation. Serine protease inhibitors, or serpins, are paradigms for this delicate balance between function and misfolding. Serpins exist in a metastable state that undergoes a major conformational change in order to inhibit proteases. However, conformational labiality of the native serpin fold renders them susceptible to misfolding, which underlies misfolding diseases such as α-antitrypsin deficiency. To investigate how serpins balance function and folding, we used consensus design to create conserpin, a synthetic serpin that folds reversibly, is functional, thermostable, and polymerization resistant. Characterization of its structure, folding and dynamics suggest that consensus design has remodeled the folding landscape to reconcile competing requirements for stability and function. This approach may offer general benefits for engineering functional proteins that have risky folding landscapes, including the removal of aggregation-prone intermediates, and modifying scaffolds for use as protein therapeutics.
PubMed: 27667094
DOI: 10.1038/srep33958
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.3 Å)
構造検証レポート
Validation report summary of 5ce0
検証レポート(詳細版)ダウンロードをダウンロード

251422

件を2026-04-01に公開中

PDB statisticsPDBj update infoContact PDBjnumon